KLOW Blend

KLOW contains four peptides — GHK-Cu, BPC-157, TB-500 (Thymosin Beta-4), and KPV. Each has its own dosing logic. This guide covers how to dose each component, what injection schedule to use, and how to reconstitute the blend.

Quickstart Highlights

KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound healing, angiogenesis, and tissue repair^[1][2]. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle healing^[3][4]. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling^[5][6]. GHK-Cu supports collagen synthesis, wound healing, and tissue regeneration^[7][8].

How It Works

KLOW combines four peptides with complementary mechanisms of action:

• TB-500 (Thymosin Beta-4): Promotes angiogenesis, cell migration, and tissue repair by regulating actin, a key protein in cell structure^[1]. Preclinical studies demonstrate accelerated wound healing, reduced inflammation, and tissue regeneration^[2].
• BPC-157: A gastric pentadecapeptide that supports tendon, ligament, and muscle healing through enhanced angiogenesis and growth factor modulation^[3]. Animal studies show favorable tissue repair outcomes^[4].
• KPV: A C-terminal tripeptide fragment of α-MSH with potent anti-inflammatory properties. It inhibits NF-κB signaling and reduces pro-inflammatory cytokines without melanotropic effects^[5][6].
• GHK-Cu: A naturally occurring copper peptide that stimulates collagen and elastin synthesis, promotes wound healing, and modulates gene expression related to tissue remodeling^[7][8].

Potential Benefits & Side Effects

Observations from preclinical and early-stage research.

Potential Benefits

• Accelerated tissue repair and wound healing through multiple complementary pathways^[1][3].
• Reduced inflammation via NF-κB inhibition and cytokine modulation^[5][7].
• Enhanced collagen synthesis and connective tissue support^[8].
• Promotion of angiogenesis and improved blood flow to healing tissues^[2].
• Potential support for musculoskeletal recovery and joint health^[3].

Possible Side Effects

• Mild injection-site reactions (redness, irritation) may occur with subcutaneous administration.
• Occasional lightheadedness reported with some peptides due to vasodilatory effects.
• Limited human clinical data; most safety observations derive from preclinical studies^[4].

References

• PubMedThymosin beta 4 accelerates wound healing (Philp et al., 1999)
• PubMedThymosin β4 promotes dermal healing in preclinical models and clinical trials
• PMCEmerging use of BPC-157 in orthopaedic sports medicine: systematic review
• PMCPharmacokinetics, distribution, metabolism, and excretion of BPC-157 in rats and dogs
• PMCPepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
• PMCOrally targeted delivery of tripeptide KPV via HA-functionalized nanoparticles alleviates ulcerative colitis
• PMCRegenerative and protective actions of the GHK-Cu peptide in light of new gene data
• PMCGHK peptide as a natural modulator of multiple cellular pathways in skin regeneration
• Sigma-AldrichHandling and storage guidelines for peptides and proteins
• CDCVaccine administration: subcutaneous injection technique guidelines
• CDCVaccine administration best practices (aspiration not recommended for SC injections)
• NCBI BookshelfChapter 18: Administration of parenteral medications (injection technique)
• PubMedThymosin β4: a multi-functional regenerative peptide (basic properties and clinical applications)
• PMCThe potential of GHK as an anti-aging peptide